ANP32E drives lung adenocarcinoma progression via GSK3β-mediated glycolytic reprogramming.
Saved in:
| Title: | ANP32E drives lung adenocarcinoma progression via GSK3β-mediated glycolytic reprogramming. |
|---|---|
| Authors: | Wang Z; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Li Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Ye Z; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wu X; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Fang C; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Jiang W; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China. whujwy0228@163.com., Zhu M; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. mzhu@tjh.tjmu.edu.cn. |
| Source: | Cell death & disease [Cell Death Dis] 2026 Apr 14; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
